alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EXHIBIT 32.2


                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



         In connection with the Annual Report of Nanoscience Technologies, Inc.,
(the "Company") on Form 10-KSB for the period ending September 30, 2006 as filed
with the Securities and Exchange  Commission on the date hereof (the  "Report"),
I,  Fred  J. Griffin,  Principal  Accounting  Officer of the  Company,  certify,
pursuant  to 18  U.S.C.  Sec.  1350,  as  adopted  pursuant  to Sec.  906 of the
Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief:

         1. The Report fully complies with the requirements of section 13 (a) or
15 (d) of the Securities and Exchange Act of 1934; and

         2. The  information  contained in the Report  fairly  presents,  in all
material  respects,  the  financial  condition  and result of  operations of the
Company.

/s/ Fred J. Griffin
-------------------------
FRED J. GRIFFIN
Interim Chief Financial Officer
January 13, 2007


A signed  original of this written  statement  required by Section 906, or other
document authenticating, acknowledging, or otherwise adopting the signature that
appears in typed form within the  electronic  version of this written  statement
has been  provided  to the  Company  and will be  retained  by the  Company  and
furnished to the Securities  and Exchange  Commission or its staff upon request.
The foregoing  certifications  are accompanying the Company's Form 10-QSB solely
pursuant to section 906 of the  Sarbanes-Oxley  Act of 2002 (subsections (a) and
(b) of section  1350,  chapter 63 of title 18,  United  States  Code) and is not
being filed as part of the Form 10-QSB or as a separate disclosure document.
#### UNITED STATES of America, Plaintiff-Appellee v. Pedro MORONES-CHAVES, Defendant-Appellant

No. 16-41235 Conference Calendar

United States Court of Appeals, Fifth Circuit.

Filed April 18, 2017

Carmen Castillo Mitchell, Assistant U.S. Attorney, U.S. Attorney’s Office, Southern District of Texas, Houston, TX, for Plaintiff-Appellee

Pedro Morones-Chaves, Pro Se

Before KING, HAYNES, and GRAVES, Circuit Judges.

PER CURIAM: *

The Federal Public Defender appointed to represent Pedro Morones-Chaves has moved for leave to withdraw and has filed a brief in accordance with *Anders v. California,*386 U.S. 738, 87 S.Ct. 1396, 18 L.Ed.2d 493 (1967), and *United States v. Flores,*632 F.3d 229 (5th Cir. 2011). Mo-rones-Chaves has not filed a response. We have reviewed counsel’s brief and the relevant portions of the record reflected therein. We concur with counsel’s assessment that the appeal presents no nonfrivolous issue for appellate review. Accordingly, counsel’s motion for leave to withdraw is GRANTED, counsel is excused from further responsibilities herein, and the APPEAL IS DISMISSED. *See*5th Cir. R. 42.2.

*

 Pursuant to 5th Cir. R. 47.5, the court has determined that this opinion should not be published and is not precedent except under the limited circumstances set forth in 5th Cir. R. 47.5.4.
**Exhibit
      32.1**




**CERTIFICATION
      OF CHIEF EXECUTIVE OFFICER AND**


**CHIEF
      FINANCIAL OFFICER**




Pursuant
      to 18 U.S.C. Sec. 1350 and in connection with the accompanying report on Form
      10-K for the fiscal year ended December 31, 2006 that is being filed
      concurrently with the Securities and Exchange Commission on the date hereof
      (the
“Report”), each of the undersigned officers of Perficient, Inc. (the “Company”),
      hereby certifies that:




1. The
      Report fully complies with the requirements of Section 13(a) or 15(d) of the
      Securities Exchange Act of 1934; and




2. The
      information contained in the Report fairly presents, in all material respects,
      the financial condition and results of operations of the Company.




Date: March
                1, 2007
            By:
            /s/ John
                T. McDonaldJohn
                T. McDonaldChief
                Executive Officer




Date: March
                1, 2007
            By:
            /s/ Paul
                E. MartinPaul
                E. MartinChief
                Financial Officer
#### In the Matter of Andre Rubinstein, Appellant, against Peter J. Haberkorn, Respondent.

Submitted February 23, 1943;

decided March 4, 1943.

*Peter J. Haberhorn*for motion.

*Henry Laufbahn*opposed.

Motion granted and appeal dismissed with costs and ten dollars costs of motion, unless appellant serves and files undertaking on appeal and pays ten dollars costs within ten days, in which event the motion is denied.
<TABLE> <S> <C>

<ARTICLE>  5

<S>                                        <C>
<PERIOD-TYPE>                              YEAR
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-END>                               DEC-31-1999
<CASH>                                          42,606
<SECURITIES>                                    30,000
<RECEIVABLES>                                  310,482
<ALLOWANCES>                                    56,927
<INVENTORY>                                    233,042
<CURRENT-ASSETS>                               591,359
<PP&E>                                         288,261
<DEPRECIATION>                                  65,765
<TOTAL-ASSETS>                               1,094,867
<CURRENT-LIABILITIES>                          609,897
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         8,661
<OTHER-SE>                                     440,680
<TOTAL-LIABILITY-AND-EQUITY>                 1,094,867
<SALES>                                        616,955
<TOTAL-REVENUES>                               652,591
<CGS>                                          300,648
<TOTAL-COSTS>                                1,165,083
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              20,204
<INCOME-PRETAX>                              (833,344)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                          (833,344)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (833,344)
<EPS-BASIC>                                     (0.10)
<EPS-DILUTED>                                   (0.10)



</TABLE>
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-START>                             JAN-01-1996
<PERIOD-END>                               SEP-30-1996
<CASH>                                       3,240,548
<SECURITIES>                                18,156,151
<RECEIVABLES>                                  309,856
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                            22,443,058
<PP&E>                                       2,623,719
<DEPRECIATION>                               (786,525)
<TOTAL-ASSETS>                              24,910,530
<CURRENT-LIABILITIES>                        2,163,343
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            84
<OTHER-SE>                                  22,747,103
<TOTAL-LIABILITY-AND-EQUITY>                24,910,530
<SALES>                                        659,000
<TOTAL-REVENUES>                               659,000
<CGS>                                          801,423
<TOTAL-COSTS>                                  801,423
<OTHER-EXPENSES>                            10,146,016
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                            (9,398,914)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (9,398,914)
<EPS-PRIMARY>                                   (1.16)
<EPS-DILUTED>                                   (1.16)
        

</TABLE>
_______________________________________ __ Michigan Supreme Court 

# Order

Lansing, Michigan

February 27, 2007 Clifford W. Taylor, Chief Justice
132651 Michael F. Cavanagh Elizabeth A. Weaver Marilyn Kelly Maura D. Corrigan PEOPLE OF THE STATE OF MICHIGAN, Plaintiff-Appellee, Robert P. Young, Jr. Stephen J. Markman, Justices

v SC: 132651 COA: 272702 Wayne CC: 05-002205-01 CANTEL RAYBURN HAYDEN, Defendant-Appellant.

________________ _______________ __________/

On order of the Court, the application for leave to appeal the October 23, 2006 order of the Court of Appeals is consider ed, and it is DENIED, because we are not persuaded that the questions presented should be reviewed by this Court.

t0220 I, Corbin R. Davis, Clerk of the Mi chigan Supreme Cour t, certify that the foregoing is a true and complete copy of the order entered at the direction of the Court.

February 27, 2007

Clerk
Exhibit 4.22

Margarette Lee                                        September 6, 2002
Young Woo & Assoc., LLC
141 Fifth Avenue
New York, NY 10010

Re: Early Termination Agreement

Dear Margarette:

Further to our discussion  from today,  this is to memorialize  the agreement we
have  reached  to  terminate  the  Agreement  of  Sublease  between  Young Woo &
Associates and Commtouch dated October 1, 1999:

     1.  Commtouch shall pay Young Woo the sum of $55,613.90.  Of that amount, a
         payment of $24,720 shall be made by way of Young Woo's retention of the
         security deposit it holds in that amount.

     2.  Of the remaining amount of $30,893.90, upon signature of this agreement
         by Young  Woo,  Commtouch  shall  either  wire funds or send a check by
         Federal Express to Young Woo in the sum of $13,200. The transference of
         the $13,200 will occur on Tuesday,  September  10, 2002.  The remainder
         totaling  $17,693.90 shall be made by wire transfer or check on October
         1, 2002.  To secure the  payment of this  remaining  amount,  Commtouch
         shall cause its parent company,  Commtouch  Software Ltd., to sign on a
         promissory note in the amount of $17,693.90.

     3.  Young Woo shall  immediately send to Commtouch by overnight  delivery a
         check it  possesses  from  Treasurace  for deposit by  Commtouch in the
         amount of $8240.

     4.  Young  Woo  shall be  transferred  title  to the  items  listed  on the
         attached  list,  which we  understand  to be located  currently  on the
         leasehold premises.

     5.  Upon execution of the above, the sublease,  including parent guarantee,
         is terminated  and each of the parties hereto waives any and all claims
         of any nature against the other party, including all related affiliates
         and  representatives.  Without derogating from the effectiveness of the
         above release, a more formal and detailed release is contemplated.

Margarette,  I appreciate your patience and courtesy  throughout this oftentimes
difficult  negotiation.  Please  sign  below and  return a signed  copy to us in
evidence of Young Woo's agreement to the above.

Regards,
/s/Gary Davis
Gary Davis
General Counsel

We agree to the above:              ______________     ________________________
                                    Commtouch Inc.     Young Woo & Assoc., LLC
# Diario Oficial C 19A/2014

| | ISSN 1977-0928
  doi:10.3000/19770928.CA2014.019.spa |
| --- | --- |
| Diario Oficial
  de la Unión Europea | C 19A |
| | |
| Edición en lengua española | Comunicaciones e informaciones | 57o año22 de enero de 2014 |

ISSN 1977-0928

doi:10.3000/19770928.CA2014.019.spa

Diario Oficial

de la Unión Europea

C 19A

Edición en lengua española

Comunicaciones e informaciones

57o año22 de enero de 2014

---

| Número de información | Sumario | Página |
| --- | --- | --- |
| | V   Anuncios |
| | PROCEDIMIENTOS ADMINISTRATIVOS |
| | Agencia Europea de Medicamentos |
| 2014/C 019A/01 | Aviso de cancelación | 1 |

Número de información

Sumario

Página

V   Anuncios

PROCEDIMIENTOS ADMINISTRATIVOS

Agencia Europea de Medicamentos

2014/C 019A/01

Aviso de cancelación

1

HISTORIAL DE LOS DIARIOS OFICIALES, SERIE C A, CONCURSOS

A continuación figura la lista de los Diarios Oficiales, serie C A, publicados en el año en curso.

Salvo indicación contraria, los Diarios Oficiales se publican en todas las versiones lingüísticas.

| 5 | |
| --- | --- |
| 6 | |
| 11 | |
| 19 | |

5

6

11

19

| ES | |
| --- | --- |

ES

---

V Anuncios

PROCEDIMIENTOS ADMINISTRATIVOS

Agencia Europea de Medicamentos

| 22.1.2014 | ES | Diario Oficial de la Unión Europea | CA 19/1 |
| --- | --- | --- | --- |

22.1.2014

ES

Diario Oficial de la Unión Europea

CA 19/1

---

Aviso de cancelación

(2014/C 19 A/01)

La Agencia Europea de Medicamentos ha decidido cancelar los siguientes procesos de selección:

| — | EMA/CA/S/039: Personal contractual (corto plazo), Apoyo Científico a la Vigilancia Europea del Consumo de Antimicrobianos de Uso Veterinario (ESVAC) (FG IV) (1)
  , |
| --- | --- |

—

EMA/CA/S/039: Personal contractual (corto plazo), Apoyo Científico a la Vigilancia Europea del Consumo de Antimicrobianos de Uso Veterinario (ESVAC) (FG IV) (1)
  ,

| — | EMA/CA/S/040: Personal contractual (corto plazo), Secretaría Científica de los Dictámenes de la Comisión Europea sobre Resistencia Antimicrobiana, Departamento de Medicamentos de Uso Veterinario (FG IV) (2)
  . |
| --- | --- |

—

EMA/CA/S/040: Personal contractual (corto plazo), Secretaría Científica de los Dictámenes de la Comisión Europea sobre Resistencia Antimicrobiana, Departamento de Medicamentos de Uso Veterinario (FG IV) (2)
  .

---

(1)  DO C 320 A de 6.11.2013, p. 2.

(2)  Véase la nota 1.

---
#### Robert Earl CLAYBORNE, Jr. Plaintiff-Appellant v. TECUMSEH DEPARTMENT OF CORRECTIONS, an agency of the State; Scott Franks, Director of the Nebraska Corrections Dept., in his official and individual capacity; Brian Gage, Warden of the Tecumseh Corrections Dept., in his official and individual capacity; Guthrie, Case worker with the Tecumseh Correction Dept., in her official and individual capacity; Tompkins, Case worker with the Tecumseh Corrections Dept., in his official and individual capacity; Keith Broadfoot, Unit Manager, Tecumseh Corrections Department, in his official and individual capacity; Sherman, Unit Administrator, Tecumseh Corrections Department, in his official and individual capacity; Crop, Officer, with the Tecumseh Corrections Dept., in his official and individual capacity. Defendants-Appellees

No. 17-1072

United States Court of Appeals, Eighth Circuit.

Submitted: October 13, 2017

Filed: November 1, 2017

*594Robert Earl Clayborne, Jr., Pro Se

Timothy Robert Ertz, Assistant Attorney General, Attorney General’s Office, Lincoln, NE, for Defendants-Appellees Tecumseh Department of Corrections, Keith Broadfoot, Unit Manager, Sherman, Unit Administrator

Timothy Robert Ertz, Assistant Attorney General, Amie Elizabeth Larson, Assistant Attorney General, Attorney General’s Office, Lincoln, NE, for Defendants-Appellees Scott Franks, Brian Gage, Guthrie, Tompkins, Crop

Before LOKEN, MURPHY, and SHEPHERD, Circuit Judges.

PER CURIAM.

In this pro se 42 U.S.C. § 1983 action, Nebraska inmate Robert Clayborne. appeals after the district court1 adversely granted summary judgment, finding defendants were entitled to qualified immunity on Clayborne’s claim that they were deliberately indifferent to his needs during a prison riot.

Having carefully reviewed the record, and the parties’ arguments on appeal, we conclude that the district court properly granted summary judgment. See Beaulieu v. Ludeman, 690 F.3d 1017, 1024 (8th Cir. 2012) (grant of summary judgment is reviewed de novo, viewing record in light most favorable to nonmovant); see also Pearson v. Callahan, 555 U.S. 223, 232, 129 S.Ct. 808, 172 L.Ed.2d 565 (2009) (to determine if defendant is entitled to qualified immunity, court must consider whether facts establish violation of constitutional or statutory right, and whether right was so clearly established that reasonable official would have known his actions were unlawr ful); Nelson v. Corr. Med. Servs., 583 F.3d 522, 528 (8th Cir. 2009) (in cases involving prison riots, wantonness necessary for deliberate indifference is demonstrated by prison officials acting “maliciously and sadistically for the very purpose of causing harm”). Accordingly, the judgment is affirmed, see 8th Cir. R. 47B, and Clayborne’s motion for a settlement conference is denied as moot.

1

. The Honorable Richard G, Kopf, United States District Judge for the District of Nebraska.
Exhibit 10.3 Board of Directors Resolutions


Exhibit 10.3




CREATIVE EDGE NUTRITION, INC.

3276 Buford Drive, Bldg. 104, Suite 320, Buford, GA 30519




UNANIMOUS CONSENT OF DIRECTORS OF CREATUVE EDGE NUTRITION, INC. IN LIEU OF A MEETING OF THE BOARD OF DIRECTORS OF CREATIVE EDGE NUTRITION, INC. (A NEVADA CORPORATION)




Pursuant to the Authority granted to directors to take action by unanimous consent without a meeting pursuant to Nevada General Corporation Law 78.315 (pursuant to the Articles of Incorporation) of Creative Edge Nutrition, Inc. (“Creative”) the Board of Directors (“Directors”) of Creative, a Nevada corporation (the “Company”), do hereby consent to adopt, ratify, confirm and approve, as of the date indicated below, the following recitals and resolutions, as evidenced by their signature hereunder:




WHEREAS, the Directors have been presented with the proposal to authorize the issuance of 20,000,000 shares of common stock of the Company in exchange for relief of debt owed by the Company in the amount of Twenty Thousand ($20,000) Dollars represented by a Forty Three Thousand Three Hundred Eighty Four ($43,384) Dollar Promissory Note (the “Promissory Note”) dated May 2, 2012;




WHEREAS, the Directors shall specifically authorize the issuance of 20,000,000 shares of common stock of the Company to First Trust Management;




WHEREAS, the Directors believe it is in the best interest of the Company to authorize the issuance of the common stock to First Trust Management in exchange for relief of the debt represented by the Promissory Note as set forth herein;




NOW, BE IT RESOLVED, that it is hereby authorized and approved to issue 20,000,000 shares of common stock of the Company to First Trust Management in exchange for relief of the debt represented by the Promissory Note.




GENERAL RESOLUTIONS




RESOLVED, that the officers of the Company are hereby authorized and instructed to take whatever steps necessary to effectuate the above described resolutions.




FURTHER RESOLVED, that the Promissory Note shall be restated and amended to show that a payment in the amount of $20,000 on the Promissory Note has been satisfied by the Company.




(Remainder of page intentionally left blank; signature page to follow)








IN WITNESS WHEREOF, the undersigned have set forth their hands in their capacity as of this 2nd day of May, 2012.




/s/ Bill Chaaban                                     

Bill Chaaban, President, CEO, Director




/s/ Reid Stone                                        

REID STONE, Vice President, Director









2
---

**EXHIBIT 31.1**

**CERTIFICATION OF PERIODIC REPORT**

I,
  Michael Gelmon, certify that:

1. I have reviewed this annual
report on Form 10-KSB of Banyan Corporation (the "Registrant");

2. Based on my knowledge, this
annual report does not contain any untrue statement of a material fact or omit
to state a material fact necessary to make the statements made, in light of the
circumstances under which such statements were made, not misleading with respect
to the period covered by this annual report;

3. Based on my knowledge, the
financial statements, and other financial information included in this annual
report, fairly present in all material respects the financial condition, results
of operations and cash flows of the Registrant as of, and for, the periods
presented in this annual report;

4. The Registrant's other
certifying officer and I are responsible for establishing and maintaining
disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and
15d-14) for the Registrant and we have:

a) designed such disclosure
controls and procedures to ensure that material information relating to the
Registrant, including its consolidated subsidiaries, is made known to us by
others within those entities, particularly during the period in which this
annual report is being prepared;

b) evaluated the effectiveness of
the Registrant's disclosure controls and procedures as of a date within 90 days
prior to the filing date of this annual report (the "Evaluation Date"); and

c) presented in this annual
report our conclusions about the effectiveness of the disclosure controls and
procedures based on our evaluation as of the Evaluation Date.

5. The Registrant's other
certifying officer and I have disclosed, based on our most recent evaluation, to
the Registrant's auditors and the audit committee of Registrant's board of
directors (or persons performing the equivalent function):

a) all significant deficiencies
in the design or operation of internal controls which could adversely affect the
Registrant's ability to record, process, summarize and report financial data and
have identified for the Registrant's auditors any material weaknesses in
internal controls; and

b) any fraud, whether or not
material, that involves management or other employees who have a significant
role in the Registrant's internal controls; and

6. The Registrant's other certifying officer and I have indicated in this annual report whether or not there were significant changes in internal controls or in other factors that could significantly affect internal
controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.

Date: April 16, 2007

| | /s/ Michael Gelmon                     
| | ---------------------------------------
| |                                        
| | Michael Gelmon, Chief Executive Officer

---